Top Markets
Coin of the day
Shanghai Runda Medical Technology Co., Ltd. Shanghai Runda Medical Technology Co., Ltd.

Shanghai Runda Medical Technology Co., Ltd.

603108
Rank in Stocks #10289
Shanghai Runda Medical Technology Co., Ltd. delivers a comprehensive array of... Shanghai Runda Medical Technology Co., Ltd. delivers a comprehensive array of integrated medical laboratory solutions throughout China. The company's extensive offerings cover vital operational aspects for laboratories, including the provision of essential platforms, expert design and refurbishment services for facilities, the establishment of standardization protocols, and the implementation of advanced information management systems. Furthermore, Shanghai Runda supports healthcare professionals by providing medical solutions for critical diagnostic fields such as biochemistry, diabetes, Point-of-Care Testing (POCT), immunoassay analysis, and molecular biology. Alongside these, they also furnish professional technical assistance and efficient logistical services. Established in 1999, the firm is headquartered in Shanghai, China.
Share Price
$1.42
Last synced: 2026-08-28
Market Cap
$860.38M
Change (1 day)
0.92%
Change (1 year)
-42.25%
Country
CN
Trade Shanghai Runda Medical Technology Co., Ltd. (603108)

Category

Revenue for Shanghai Runda Medical Technology Co., Ltd. (603108)
Revenue in Aug 2026 TTM: 0
According to Shanghai Runda Medical Technology Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shanghai Runda Medical Technology Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$4.55B -
US